MANAGED ACCESS:
NAME PATIENT PROGRAMMES

FarmaMondo managed access: name patient programmes

We set up paid market access programmes for innovative specialty medicines:

  • farmamondo-wireframe-world
    A comprehensive package of services put in place to ethically address unsolicited requests from healthcare providers for paid access Named Patient Programmes (NPPs);
  • farmamondo-wireframe-world
    An exclusive and centralized access route with regulatory, compliance, payer and funding solutions as well as a global logistics and distribution infrastructure.

The Group offers both paid access and pro-bono (compassionate) access programmes through a comprehensive service package with a fair financial structure and flexible commercial terms to meet our partners’ objectives.

Examples of programmes executed across various geographical regions are listed below. For more information, please contact FarmaMondo offices in your region or our Medical Affairs teams.

Therapeutic areaIndicationsGeographical scope
OncologyEpithelial ovarian cancer / fallopian tube cancerTargeted markets
Chemotherapy induced neutropeniaTargeted markets
Haemato-oncologyAcute promyelocytic leukemiaTargeted markets
Multiple myelomaTargeted markets
Acute lymphoblastic leukemia (ALL)Global
Pediatric oncology/haematologyNeuroblastomaTargeted markets
Metabolic disease orphanWilson's disease (orphan)Targeted markets
Congenital or acquired generalized lipodystrophyTargeted markets
Homozygous familial hypercholesterolemiaTargeted markets
Gaucher diseaseGlobal
Alagille syndrome (ALGS)Targeted markets
Progressive familial intrahepatic cholestasis (PFIC)Targeted markets
Neurology orphanAllan-Herndon-Dudley syndromeTargeted markets
Duchenne muscular dystrophyTargeted markets
Ophthalmology orphanNeurotrophic keratitisTargeted markets
Dermatology orphanEpidermolysis bullosa (EB)Targeted markets

PLEASE CONTACT US FOR FURTHER QUESTIONS AND INFORMATION

  • If you would like to send us a general enquiry, please complete the following form.